drugset / Trial / NCT03134612

Comparison Between Ondansetron 8 mg and Lidocain 40 mg in Preventing Pain Due to Propofol Injection

NCT03134612

Phase 2 Completed 104 enrolled Indonesia University
RandomizedParallel-groupDouble-blindSupportive care

Summary

This study aims to compare the effectivity between ondansetron 8 mg and lidocain 40 mg in preventing pain due to propofol injection

Timeline

Start
2016-07
Primary completion
2016-09
Completion
2016-09

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lidocaine Other / unclassified 40 mg Intravenous
Comparator Ondansetron Other / unclassified 8 mg Intravenous

Indications

No indication recorded.